Table 2.
High risk pathological features by immune status
| Pathological feature | All patients N = 66 |
Immunocompetent N = 42 |
Immunosuppressed N = 24 |
HIV N = 8 |
Other immunosuppreseda N = 16 |
|---|---|---|---|---|---|
| Tumor diameter > 2 cm | 27 (41%) | 19 (45%) | 8 (33%) | 2 (25%) | 6 (38%) |
| Tumor thickness > 2 mm | 33 (50%) | 21 (50%) | 12 (50%) | 3 (38%) | 9 (56%) |
| PNI | 11 (17%) | 10 (24%) | 1 (4%) | 0 (-) | 1 (6%) |
| Poorly differentiated histology | 13 (20%) | 6 (14%) | 7 (29%) | 1 (13%) | 6 (38%) |
| LN involved | 2 (3%) | 0 (–) | 2 (8%) | 1 (13%) | 1 (6%) |
| LVI | 8 (12%) | 5 (12%) | 3 (13%) | 0 (0%) | 3 (19%) |
PNI perineural invasion, LVI lymphovascular invasion
aOther immunosuppressed consists of 12 organ transplant patients and 4 of other etiology (CLL, inflammatory bowel disease on immunosuppression)